NantHealth (NH) and The Competition Critical Contrast
NantHealth (NASDAQ: NH) is one of 20 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it weigh in compared to its peers? We will compare NantHealth to similar companies based on the strength of its valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.
This is a breakdown of current recommendations for NantHealth and its peers, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
NantHealth currently has a consensus target price of $9.00, indicating a potential upside of 181.25%. As a group, “Medical Software & Technology Services” companies have a potential upside of 16.76%. Given NantHealth’s stronger consensus rating and higher probable upside, research analysts clearly believe NantHealth is more favorable than its peers.
Insider and Institutional Ownership
7.1% of NantHealth shares are owned by institutional investors. Comparatively, 62.8% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 58.0% of NantHealth shares are owned by company insiders. Comparatively, 26.5% of shares of all “Medical Software & Technology Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares NantHealth and its peers revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|NantHealth||$100.38 million||-$184.10 million||-2.19|
|NantHealth Competitors||$413.57 million||-$24.55 million||407.65|
NantHealth’s peers have higher revenue and earnings than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
This table compares NantHealth and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
NantHealth peers beat NantHealth on 8 of the 12 factors compared.
NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with Analyst Ratings Network's FREE daily email newsletter.